Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2014
11/20/2014US20140343051 Methods to modulate acute myeloid leukemia stem/progenitor cell expansion and/or differentiation
11/20/2014US20140343045 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
11/20/2014US20140343041 Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine Headache
11/20/2014US20140343037 Benzene, pyridine, and pyridazine derivatives
11/20/2014US20140343021 Adjuvant to thrombolytic therapy for the treatment of frostbite
11/20/2014US20140343014 Combination of a certain dpp-4 inhibitor and voglibose
11/20/2014US20140343011 Methods for treating or preventing urological inflammation
11/20/2014US20140343006 HIV Replication Inhibiting Pyrimidines
11/20/2014US20140343003 Method for treating lyme disease
11/20/2014US20140343000 Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
11/20/2014US20140342998 Quinone based nitric oxide donating compounds
11/20/2014US20140342996 Treatments for Gastrointestinal Disorders
11/20/2014US20140342994 Fusion Protein Comprising Circularly Permuted Form Of Trail/Apo2L, Coding Gene And Use Thereof
11/20/2014US20140342989 Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
11/20/2014US20140342987 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342009 Boswellia oil, its fractions and compositions for enhancing brain function
11/20/2014US20140341994 Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
11/20/2014US20140341988 Orally dispersible drug formulations
11/20/2014US20140341986 Biguanide Compositions and Methods of Treating Metabolic Disorders
11/20/2014US20140341979 Nanodrug targeting protein geranylgeranylation
11/20/2014US20140341975 Pathogen and substance traps
11/20/2014US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/20/2014US20140341937 Methods and Compositions for Modulating Immune Tolerance
11/20/2014US20140341926 Method for egfr directed combination treatment of cancer
11/20/2014US20140341923 Human Rhinovirus (HRV) Antibodies
11/20/2014US20140341921 Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
11/20/2014US20140341913 Methods and compositions for treating asthma using anti-il-13 antibodies
11/20/2014US20140341912 Monoclonal antibodies directed to cd52
11/20/2014US20140341901 Compositions and methods of use for antibodies of dickkopf-1
11/20/2014US20140341900 Methods of treating cancer
11/20/2014US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES
11/20/2014US20140341879 Methods for the prevention or treatment of vessel occlusion injury
11/20/2014US20140341867 Treatment of stroke using isolated placental cells
11/20/2014US20140341851 Novel benzimidazole derivatives
11/20/2014US20140341850 Haloalkyl heteroaryl benzamide compounds
11/20/2014US20140341849 Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
11/20/2014US20140341848 4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
11/20/2014US20140341847 4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
11/20/2014US20140341810 Antagonists for abdominal vasopressin v2 receptor and uses thereof
11/20/2014US20140341804 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (pmsa) and uses thereof
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/18/2014US8889871 Hepatitis C virus inhibitors
11/18/2014US8889736 Formulations for the treatment of pain
11/18/2014US8889724 Tetrazole compounds for reducing uric acid
11/18/2014US8889720 Non-flushing niacin analogues, and methods of use thereof
11/18/2014US8889712 IAP antagonists
11/18/2014US8889708 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
11/18/2014US8889707 Treatment of addiction
11/18/2014US8889705 Noscapine analogs and their use in treating cancers
11/18/2014US8889701 Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate
11/18/2014US8889700 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
11/18/2014US8889691 Indole compounds as an inhibitor of cellular necrosis
11/18/2014US8889689 Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
11/18/2014US8889669 Cytotoxic benzodiazepine derivatives
11/18/2014US8889668 Oxadiazole diaryl compounds
11/18/2014US8889659 Pain relief compositions, manufacture and uses
11/18/2014US8889630 Method for hair regrowth using Granulocyte-Colony Stimulating Factor
11/18/2014US8889621 Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
11/18/2014US8889615 Methods for promoting epithelialization and healing of chronic wounds
11/18/2014US8889426 Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia
11/18/2014US8889375 Hypoglycemic effect enhancer
11/18/2014US8889194 Smoking cessation with body weight maintenance and nutritional supplement
11/18/2014US8889188 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses
11/18/2014US8889187 Once a day amoxicillin product comprising immediate and delayed release dosage forms
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889175 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
11/18/2014US8889170 Implantable device having a coating with a triblock copolymer
11/18/2014US8889153 Combination of immunomodulator and anti-pathogenic agent
11/18/2014US8889152 Capsular polysaccharides solubilisation and combination vaccines
11/18/2014US8889144 PCSK9 vaccine
11/18/2014US8889134 Modulators of Candida hyphal morphogenesis and uses thereof
11/18/2014US8889115 Ion binding polymers and uses thereof
11/18/2014US8889112 Ophthalmic formulations including selective alpha 1 antagonists
11/18/2014US8888736 High shear application in medical therapy
11/18/2014US8887721 Attenuation of vasoactive oxygen carrier-induced vasoconstriction
11/13/2014US20140336440 Inhibitors of rho associated protein kinases (rock) and methods of use
11/13/2014US20140336359 Synthetic peptides for treatment of bacterial infections
11/13/2014US20140336258 Anti-virulence compositions and methods
11/13/2014US20140336248 Therapeutic compositions and related methods of use
11/13/2014US20140336244 Methods and products for reawakening retrocyclins
11/13/2014US20140336243 Lipid Formulated Compositions and Methods for Inhibiting Expression of Eg5 and VEGF Genes
11/13/2014US20140336240 Method of treating hyperlipidemia and atherosclerosis with mir-30c
11/13/2014US20140336229 Pharmaceutical composition for preventing or treating hyperlipidemia
11/13/2014US20140336228 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
11/13/2014US20140336210 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/13/2014US20140336207 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof
11/13/2014US20140336205 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use
11/13/2014US20140336204 Methods of inhibiting xanthine oxidase activity in a cell
11/13/2014US20140336194 Method of treating contrast-induced nephropathy
11/13/2014US20140336177 Inhibitors of the renal outer medullary potassium channel
11/13/2014US20140336172 Novel 2H-Indazoles as EP2 Receptor Antagonists
11/13/2014US20140336171 Azaindoles useful as inhibitors of janus kinases
11/13/2014US20140336168 Nampt inhibitors
11/13/2014US20140336159 Methods for treating and diagnosing respiratory tract infections
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140336148 Combinations of diacerein and non-steroidal inflammation drugs
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140336138 Compositions and methods for screening and treatment of sturge-weber syndrome, klippel-trenaunay-weber syndrome, and port-wine stains (pwss)
11/13/2014US20140336131 Methods for treating inflammation, autoimmune disorders and pain
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 1151